Current treatment strategy of the German CLL Study group.

For further explanations see text or contact www.dcllsg.de.

Abbreviations: ARANESP, darbepoietin alfa; CLL, chronic lymphocytic leukemia; FC, fludarabine plus cyclophosphamide; FCR, fludarabine, cyclophosphamide plus rituximab; GCLLSG, German CLL study group; MRD, minimal residual disease.